Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Prabuddha Kumar"'
Autor:
Saumyabrata Mazumder, Ruchir Rastogi, Avinash Undale, Kajal Arora, Nupur Mehrotra Arora, Biswa Pratim, Dilip Kumar, Abyson Joseph, Bhupesh Mali, Vidya Bhushan Arya, Sriganesh Kalyanaraman, Abhishek Mukherjee, Aditi Gupta, Swaroop Potdar, Sourav Singha Roy, Deepak Parashar, Jeny Paliwal, Sudhir Kumar Singh, Aelia Naqvi, Apoorva Srivastava, Manglesh Kumar Singh, Devanand Kumar, Sarthi Bansal, Satabdi Rautray, Manish Saini, Kshipra Jain, Reeshu Gupta, Prabuddha Kumar Kundu
Publikováno v:
Heliyon, Vol 7, Iss 10, Pp e08124- (2021)
The rapid development of safe and effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) is a necessary response to coronavirus outbreak. Here, we developed PRAK-03202, the world's first triple antigen virus-like part
Externí odkaz:
https://doaj.org/article/0dfd59dfde2d410a8ba0a7733014be0b
Autor:
Saumyabrata Mazumder, Ruchir Rastogi, Avinash Undale, Kajal Arora, Nupur Mehrotra Arora, Biswa Pratim, Dilip Kumar, Abyson Joseph, Bhupesh Mali, Vidya Bhushan Arya, Sriganesh Kalyanaraman, Abhishek Mukherjee, Aditi Gupta, Swaroop Potdar, Sourav Singha Roy, Deepak Parashar, Jeny Paliwal, Sudhir Kumar Singh, Aelia Naqvi, Apoorva Srivastava, Manglesh Kumar Singh, Devanand Kumar, Sarthi Bansal, Satabdi Rautray, Manish Saini, Kshipra Jain, Reeshu Gupta, Prabuddha Kumar Kundu
Publikováno v:
Heliyon, Vol 7, Iss 10, Pp e08201- (2021)
Externí odkaz:
https://doaj.org/article/117420d8026e444fbb9e9805bd44c6ef
Autor:
Mazumder, Saumyabrata, Rastogi, Ruchir, Undale, Avinash, Arora, Kajal, Arora, Nupur Mehrotra, Pratim, Biswa, Kumar, Dilip, Joseph, Abyson, Mali, Bhupesh, Arya, Vidya Bhushan, Kalyanaraman, Sriganesh, Mukherjee, Abhishek, Gupta, Aditi, Potdar, Swaroop, Roy, Sourav Singha, Parashar, Deepak, Paliwal, Jeny, Singh, Sudhir Kumar, Naqvi, Aelia, Srivastava, Apoorva, Singh, Manglesh Kumar, Kumar, Devanand, Bansal, Sarthi, Rautray, Satabdi, Saini, Manish, Jain, Kshipra, Gupta, Reeshu, Kundu, Prabuddha Kumar
Publikováno v:
In Heliyon October 2021 7(10)
Autor:
R. S. Gupta, Ambica Baru, Swati Sharma, Saumyabrata Mazumdar, Nupur Mehrotra Arora, Sameena Khan, Prabuddha Kumar Kundu, Biswa Pratim Das Purakayastha
Publikováno v:
ASSAY and Drug Development Technologies. 19:361-372
The latest advancements in oncology are majorly focused on immuno-oncology (I-O) therapies. However, only ∼7% of drugs are being approved from the preclinical discovery phase to phase 1. The most challenging issues in I-O are the development of act
Autor:
Aelia Naqvi, Kajal Arora, Ruchir Rastogi, Jeny Paliwal, Apoorva Srivastava, Sriganesh Kalyanaraman, Deepak Parashar, Manish Saini, Prabuddha Kumar Kundu, Nupur Mehrotra Arora, Sudhir Kumar Singh, D. Kumar, Bhupesh Mali, Manglesh Kumar Singh, Vidya Bhushan Arya, Biswa Pratim, Abhishek Mukherjee, Avinash Undale, Swaroop Potdar, Saumyabrata Mazumder, Dilip Kumar, Sarthi Bansal, Aditi Gupta, Sourav Roy, Abyson Joseph, R. S. Gupta, Satabdi Rautray, Kshipra Jain
Publikováno v:
Heliyon, Vol 7, Iss 10, Pp e08201-(2021)
Autor:
Mazumder, Saumyabrata, Rastogi, Ruchir, Undale, Avinash, Arora, Kajal, Arora, Nupur Mehrotra, Pratim, Biswa, Kumar, Dilip, Joseph, Abyson, Mali, Bhupesh, Arya, Vidya Bhushan, Kalyanaraman, Sriganesh, Mukherjee, Abhishek, Gupta, Aditi, Potdar, Swaroop, Roy, Sourav Singha, Parashar, Deepak, Paliwal, Jeny, Singh, Sudhir Kumar, Naqvi, Aelia, Srivastava, Apoorva, Singh, Manglesh Kumar, Kumar, Devanand, Bansal, Sarthi, Rautray, Satabdi, Saini, Manish, Jain, Kshipra, Gupta, Reeshu, Kundu, Prabuddha Kumar
Publikováno v:
In Heliyon October 2021 7(10)
Autor:
Sameena Khan, Nupur Mehrotra Arora, Ambica Baru, Prabuddha Kumar Kundu, Saumyabrata Mazumdar, Swati Sharma, Biswa Pratim Das Purakayastha, R. S. Gupta
The formation of three-dimensional spheroid tumor model using the scaffold-based platforms has been demonstrated over many years now. 3D tumor models are generated mainly in non-scalable culture systems, using synthetic and biological scaffolds. Many
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf4b11faf7317b1f2d63ec8b4525617d
https://doi.org/10.1101/2020.12.21.423825
https://doi.org/10.1101/2020.12.21.423825
Autor:
R. S. Gupta, Prabuddha Kumar Kundu, Nupur Mehrotra Arora, Sameena Khan, Purkayastha Bpd, Saumyabrata Mazumder, Swati Sharma, Ambica Baru
The latest advancements in oncology are majorly focused on immuno-oncology (I-O) therapies. However, only ~7% of drugs are being approved from the preclinical discovery phase to phase 1. The most challenging issues in I-O is the problem of developing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba4341dcb7fc75a2c425b19194d7585e
https://doi.org/10.1101/2020.11.05.369751
https://doi.org/10.1101/2020.11.05.369751
Autor:
Sriganesh Kalyanaraman, Biswa Pratim Das Purkayastha, Kajal Arora, Nupur Mehrotra Arora, Manish Saini, Apoorva Srivastava, Manglesh Kumar Singh, Aditi Gupta, Prabuddha Kumar Kundu, Sourav Roy, Avinash Undale, Saumyabrata Mazumder, D. Kumar, Swaroop Potdar, Dilip Kumar, Bhupesh Mali, Jeny Paliwal, Bivekanand Kumar, Aelia Naqvi, Abyson Joseph, R. S. Gupta, Satabdi Rautray, Abhishek Mukherjee, Indrajeet Singh, Kshipra Jain, Sarthi Bansal, Ruchir Rastogi, Sudhir Kumar Singh, Pankaj Surendra Fengade, Vidya Bhushan Arya, Deepak Parashar
The rapid development of safe and effective vaccines against SARS CoV-2 is the need of the hour for the coronavirus outbreak. Here, we have developed PRAK-03202, the world’s first triple antigen VLP vaccine candidate in a highly characterized S. ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::018355b6c840ffeb33de7fbf4324655d
https://doi.org/10.1101/2020.10.30.360115
https://doi.org/10.1101/2020.10.30.360115
Autor:
Ruchir Rastogi, Sriganesh Kalyanaraman, Nupur Mehrotra Arora, Swaroop Potdar, Sarthi Bansal, Satabdi Rautray, Pankaj Surendra Fengade, Indrajeet Singh, Sudhir Kumar Singh, Deepak Parashar, Kajal Arora, Apoorva Srivastava, Bibekanand Kumar, Aelia Naqvi, Prabuddha Kumar Kundu, Jeny Paliwal, Vidya Bhushan Arya, D. Kumar
Spike, Envelope and Membrane proteins from the SARS CoV-2 virus surface coat are important vaccine targets. We hereby report recombinant co-expression of the three proteins (Spike, Envelope and Membrane) in a engineered Saccharomyces cerevisiae platf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac80e87f599c56a756682b5b3f343df6
https://doi.org/10.1101/2020.05.18.099234
https://doi.org/10.1101/2020.05.18.099234